News & Updates
FIFO lists of applications received for enlistment of Herbal, Homeo , Neutraceutical products (Year 2024)
DISCLAIMER
“The FIFO list for year 2024 of alternative medicines and health products is prepared with due diligence for transparency of process and visibility of the stakeholders. However, errors and omissions may be accepted subject to valid evidence.”
Herbal
Homeo
Neutra
Provisional FIFO lists of applications received for provisional enlistment of Herbal, Homeo,Neutraceutical products (1st January, 2024 to 30th September, 2024).
Approved Content Weightages for Drug Regulatory Authority Government of Pakistan Adv.No.01/2024
Approved Content Weightages for Drug Regulatory Authority Government of Pakistan Adv.No.02/2024
Vacancy Announcement for the position of Chief Executive Officer, Drug Regulatory Authority of Pakistan
DRAP Newsletter: Volume 03-Issue -II, November, 2024
The Drug Regulatory Authority of Pakistan (DRAP) has released a new issue of its quarterly newsletter, featuring several key updates and initiatives. DRAP has extended the scope of its Industry E-Reporting System for Adverse Drug Reactions to all registration holders, following a successful pilot project. The newsletter details recent actions on the promotion of clinical trials regulatory oversight, the stakeholder queries management system, and interprovincial coordination for the implementation of the Institutional Development Plan as per WHO recommendations. Additionally, the newsletter covers ongoing efforts to enhance public health and safety, including increased surveillance and regulatory actions to ensure the quality and safety of therapeutic goods.
Request for Expression of Interest (EOI)
Invitation to bid: Provision of housekeeping, janitorial & support staff at DRAP offices
Draft Guidance Document For Clinical Trials Of Biological Products (Manufacture Locally)
For comments of stakeholders